Low Risk Gestational Trophoblastic Neoplasia clinical trials

Explore recruiting low risk gestational trophoblastic neoplasia clinical trials.

Recruiting low risk gestational trophoblastic neoplasia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Low Risk Gestational Trophoblastic Neoplasia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

TROPHAMET, a phase I/II trial of Avelumab and METhotrexate in low-risk gestational TROPHoblastic neoplasias as first line treatment

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Low Risk Gestational Trophoblastic Neoplasia trials by city

Low Risk Gestational Trophoblastic Neoplasia in Toronto Low Risk Gestational Trophoblastic Neoplasia in Vancouver Low Risk Gestational Trophoblastic Neoplasia in Montreal Low Risk Gestational Trophoblastic Neoplasia in Calgary Low Risk Gestational Trophoblastic Neoplasia in Edmonton Low Risk Gestational Trophoblastic Neoplasia in Ottawa Low Risk Gestational Trophoblastic Neoplasia in Winnipeg Low Risk Gestational Trophoblastic Neoplasia in Quebec City Low Risk Gestational Trophoblastic Neoplasia in Hamilton Low Risk Gestational Trophoblastic Neoplasia in Kitchener Low Risk Gestational Trophoblastic Neoplasia in London Low Risk Gestational Trophoblastic Neoplasia in Halifax Low Risk Gestational Trophoblastic Neoplasia in New York Low Risk Gestational Trophoblastic Neoplasia in Los Angeles Low Risk Gestational Trophoblastic Neoplasia in Chicago Low Risk Gestational Trophoblastic Neoplasia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease